Recommendations for Obesity Clinical Trials in Cancer Survivors: American Society of Clinical Oncology Statement
Cet article présente les recommandations de l'"American Society of Clinical Oncology" pour mener des recherches cliniques sur les patients obèses ayant survécu à un cancer
In November 2014, ASCO convened the Research Summit on Advancing Obesity Clinical Trials in Cancer Survivors. The meeting involved key stakeholders in the study of obesity and cancer, including obesity researchers, oncology providers, clinical trialists, patient advocates, governmental and private funding organizations, payers, and representatives from health systems. The primary objectives of the summit were to review and summarize the available literature, identify gaps, define research priorities, discuss the logistic and financial barriers to research in this field, and develop a roadmap for the design and implementation of studies with the potential to generate data that could support the incorporation of weight management and physical activity programs into standard oncology practice. This article summarizes key conclusions of the ASCO summit and provides recommendations for the development of a coordinated research agenda of obesity clinical trials in cancer survivors.
Journal of Clinical Oncology , article en libre accès, 2015